Related Experiment Video
Updated: Aug 6, 2026

07:54
Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Maxillomandibular Advancement Outcomes in Obstructive Sleep Apnea by Age and Gender
Matthew O Herbst1, Lucas C Licaj1, Ethan M Kallenberger1
1Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
The Laryngoscope
|July 20, 2026
Summary
Maxillomandibular advancement (MMA) effectively treats obstructive sleep apnea (OSA) regardless of patient age or gender. Older adults may have a slightly lower chance of surgical cure, warranting specific counseling.
Area of Science:
- Surgical treatment outcomes
- Sleep medicine
- Otolaryngology
Background:
- Maxillomandibular advancement (MMA) is a highly effective surgical intervention for obstructive sleep apnea (OSA).
- The impact of patient demographics like age and gender on MMA efficacy is not well-established.
- This study addresses this gap by analyzing MMA outcomes stratified by age and gender.
Purpose of the Study:
- To evaluate the outcomes of maxillomandibular advancement (MMA) surgery for obstructive sleep apnea (OSA).
- To determine if patient age and gender influence the success and cure rates of MMA.
- To provide evidence-based insights for patient selection and counseling.
Main Methods:
- A systematic meta-analysis was conducted using data from CINAHL, Cochrane Library, PubMed, and Scopus.
- Included studies reported age- or gender-specific outcomes for adult OSA patients undergoing MMA.
- Key outcome measures included cephalometric changes, apnea-hypopnea index (AHI), Epworth Sleepiness Scale (ESS), SpO2 nadir, surgical success, and cure rates.
Main Results:
- MMA significantly improved AHI, ESS, and LSAT in OSA patients (p < 0.05).
- No significant differences in treatment improvement were observed between males and females or across different age groups.
- While surgical success and cure rates were comparable between genders, increasing age was associated with a statistically significant decrease in the odds of cure (OR=0.97 annually, p=0.029).
Conclusions:
- Maxillomandibular advancement is a robust treatment for OSA, offering significant benefits irrespective of patient age or gender.
- Outcomes are generally consistent across demographic groups.
- Clinicians should discuss the slightly reduced likelihood of complete surgical cure with older adult patients.